During the past decade, Kinugawa Cardiology Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinugawa Cardiology Clinic" #1 collaborator was "Teijin Pharma Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kinugawa Cardiology Clinic" are "Dyslipidemias" (1 trials) and "Hyperuricemia" (1 trials). Many other conditions were trialed in "Kinugawa Cardiology Clinic" in a lesser frequency.

Most popular intervention types in "Kinugawa Cardiology Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Febuxostat" (1 trials), "K-877 ER 0.2 mg/day evening administration (once daily)" (1 trials) and "K-877 ER 0.2 mg/day morning administration (once daily)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kinugawa Cardiology Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kinugawa Cardiology Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kinugawa Cardiology Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kinugawa Cardiology Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".